L-Methionine SR-sulfoximine-resistant glutamine synthetase from mutants of Salmonella typhimurium.
Two mutants of Salmonella typhimurium resistant to growth inhibition by the glutamine synthetase transition state analog, L-methionine SR-sulfoximine, were isolated and characterized. These mutants are glutamine bradytrophs and cannot use growth rate-limiting nitrogen sources. Although this phenotype resembles that of mutants with lesions in the regulatory gene for glutamine synthetase, glnG, these mutations do not lie in the glnG gene. Purification and characterization of the glutamine synthetase from one of the mutants and a control strain demonstrated that the mutant enzyme is defective in the reverse gamma-glutamyltransferase activity but has biosynthetic activity that is resistant to inhibition by L-methionine SR-sulfoximine. The mutant enzyme also has a 4.4-fold higher apparent Km for glutamate (0.2 mM versus 2.1 mM, respectively) and a 13.8-fold higher Km for NH3 (6.4 mM versus 0.46 mM) than the enzyme from the control. These data show that the glutamine synthetase protein has been altered by this mutation, designated as glnA982, and suggest that the L-methionine SR-sulfoximine resistance is conferred by a change in the NH3 binding domain of the enzyme.
D004352:Drug Resistance, Microbial; D005838:Genotype; D005974:Glutamate-Ammonia Ligase / Q000378:metabolism*; D007536:Isomerism; D007700:Kinetics; D008717:Methionine Sulfoximine / Q000494:pharmacology*; D009154:Mutation; D012486:Salmonella typhimurium / Q000201:enzymology* / Q000302:isolation & purification; D013045:Species Specificity
D008717:Methionine Sulfoximine; D005974:Glutamate-Ammonia Ligase